innoscripta Expands in Austria with Over EUR 1 Million Order Backlog

innoscripta SE (ISIN: DE000A40QVM8) is accelerating its expansion in Austria, a market that has been established for 24 years. The company's dedicated Austrian sales team, formed this year, has already secured more than 30 Austrian companies as customers, generating an order backlog exceeding EUR 1 million from concrete projects. This success underscores the growing importance of the Austrian R&D tax credit, which has been in place since 2002 and offers a 14% tax credit on qualifying research and development expenditures.

The Austrian market's potential is significant: in 2024, Austrian companies applied for a total funding volume of EUR 1.4 billion, surpassing the approximately EUR 1.2 billion paid out under Germany's R&D tax allowance in 2025, despite Austria's smaller size. This highlights the attractiveness of the Austrian market for companies like innoscripta that specialize in optimizing R&D tax incentives.

innoscripta has had an office in Vienna since 2021, which previously served mainly to attract talent for its German operations. Now, with a dedicated team focusing on the Austrian R&D tax credit, the company is capitalizing on this existing presence to drive growth. The new customers span a wide range of sectors, including industry and manufacturing, software and IT, logistics, and retail, demonstrating the cross-industry applicability of innoscripta's platform.

Sebastian Schwertlein, COO of innoscripta SE, commented, "Our rapid market success in Austria is further evidence of the competitiveness of our software-centric approach with the innovative Clusterix platform. We are particularly pleased to have attracted a broad range of new customers across different sectors, including industry and manufacturing, software and IT, logistics, and retail. This demonstrates that our approach works across industries."

The expansion into Austria is part of innoscripta's broader international strategy, following its market entries in France, the United Kingdom, and the United States. The company's flagship product, Clusterix, is a scalable software platform designed to help companies structure and manage their research and development activities efficiently. By digitizing internal processes and making R&D activities transparent, Clusterix enables businesses to maximize their innovation potential and benefit from government incentives.

The implications of innoscripta's success in Austria are twofold. First, it validates the growing demand for specialized software solutions that streamline R&D tax credit applications, a niche that is becoming increasingly important as governments worldwide offer incentives to boost innovation. Second, it signals that Austria, despite its smaller economy, is a lucrative market for such services, with funding volumes exceeding those of its larger neighbor, Germany. This could encourage other companies in the R&D tax credit space to consider Austria as a key market.

For more information about innoscripta and its Clusterix platform, visit the company's website at innoscripta.de.